UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Unplanned admissions for patients with myeloma in the UK: Low frequency but high costs

Kolovos, S; Nador, G; Kishore, B; Streetly, M; Rabin, NK; Chantry, AD; Yong, K; ... Pinedo-Villanueva, R; + view all (2019) Unplanned admissions for patients with myeloma in the UK: Low frequency but high costs. Journal of Bone Oncology , 17 , Article 100243. 10.1016/j.jbo.2019.100243. Green open access

[img]
Preview
Text
Unplanned admissions for patients with myeloma in the UK Low frequency but high costs.pdf - Published version

Download (1MB) | Preview

Abstract

Background: Multiple myeloma (MM) is associated with high healthcare resource utilisation and increasing hospitalisation rates. The aim of this study was to characterise the hospital use by patients with MM in the English National Health Service (NHS). Methods: Routinely-collected aggregate data about all NHS-funded hospital admissions of patients with MM were analysed. Data were obtained from the English Hospital Episodes Statistics on admissions between 1 April 2014 and 31 March 2018. Results: A total of 754,345 admissions were reported over four years, equivalent to a mean of 188,586 admissions per year. Of the 41,845 patients admitted during this period, 42% were women and 58% men. From the total admissions, 90% were elective and 10% unplanned. Mean annual estimated costs over the period were £46 million for elective and £56 million for unplanned admissions. The number of elective admissions increased by 4.5% with costs increasing 1.5% per year; for unplanned admissions, these figures were 4.1% and 9.0%, respectively. Conclusions: MM is associated with a significant number of hospital admissions and NHS costs. The majority of the hospital admissions are elective, but the highest burden in terms of costs relates to unplanned admissions, with numbers increasing over time.

Type: Article
Title: Unplanned admissions for patients with myeloma in the UK: Low frequency but high costs
Location: Netherlands
Open access status: An open access version is available from UCL Discovery
DOI: 10.1016/j.jbo.2019.100243
Publisher version: https://doi.org/10.1016/j.jbo.2019.100243
Language: English
Additional information: Copyright © 2019 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).
Keywords: Costs, Elective admissions, Multiple myeloma, Unplanned admissions
UCL classification: UCL > Provost and Vice Provost Offices
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Haematology
URI: https://discovery.ucl.ac.uk/id/eprint/10081399
Downloads since deposit
17Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item